Endoscopic Injection Needle Market Size, Share, Growth, and Industry Analysis, By Type (Diameter 19G, Diameter 22G, Diameter 23G, Diameter 25G, Diameter 26G, Others), By Application (Hospitals, Clinics, Others), Regional Insights and Forecast to 2035

Endoscopic Injection Needle Market Overview

The Endoscopic Injection Needle Market size valued at USD 492.36 million in 2026 and is expected to reach USD 768.84 million by 2035, growing at a CAGR of 4.6% from 2026 to 2035.

The Endoscopic Injection Needle Market plays a critical role in gastrointestinal therapeutic procedures, supporting more than 30 million endoscopic procedures annually worldwide. These needles are used in approximately 65% of endoscopic interventions, including hemostasis, polypectomy, and submucosal injections. The Endoscopic Injection Needle Market Report indicates that over 70% of gastroenterologists use disposable injection needles to minimize cross-contamination risks. Needle lengths typically range between 3 mm and 8 mm, with diameters from 19G to 26G supporting different clinical needs. The Endoscopic Injection Needle Market Analysis shows that over 1.8 million gastrointestinal bleeding cases annually require injection therapy using endoscopic needles.

The United States accounts for a major share of the Endoscopic Injection Needle Market, with more than 18 million endoscopic procedures conducted annually. The Endoscopic Injection Needle Market Research Report highlights that approximately 7,000 hospitals and 16,000 outpatient centers perform procedures requiring injection needles. Over 85% of therapeutic endoscopies in the U.S. involve injection techniques for hemostasis and lesion management. The Endoscopic Injection Needle Industry Report indicates that more than 200,000 gastrointestinal bleeding cases annually require injection therapy. Disposable injection needles are used in approximately 90% of procedures, reducing infection risks to below 3% incidence rates.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: Gastrointestinal procedures contribute 48%, bleeding management represents 26%, polypectomy applications account for 16%, and tumor treatments contribute 10% to Endoscopic Injection Needle Market Growth.
• Major Market Restraint: High device costs impact 32%, procedural complications affect 27%, limited skilled professionals contribute 23%, and regulatory challenges represent 18% of Endoscopic Injection Needle Industry limitations.
• Emerging Trends: Disposable needles account for 44%, safety-enhanced designs represent 26%, ultra-thin needles contribute 18%, and multi-function needles hold 12% of Endoscopic Injection Needle Market Trends.
• Regional Leadership: North America holds 38% of Endoscopic Injection Needle Market Share, Europe represents 29%, Asia-Pacific accounts for 25%, and Middle East & Africa contribute 8%.
• Competitive Landscape: Top 5 companies control 60% of Endoscopic Injection Needle Market Share, top 2 players represent 43%, mid-tier companies account for 32%, and emerging players hold 25%.
• Market Segmentation: Diameter 22G represents 36% of Endoscopic Injection Needle Market Size, 23G accounts for 24%, 25G represents 18%, 19G contributes 12%, 26G accounts for 6%, and others represent 4%.
• Recent Development: Safety needle designs represent 34%, improved material durability contributes 28%, precision injection systems account for 22%, and multi-lumen technologies represent 16%.

Endoscopic Injection Needle Market Latest Trends

The Endoscopic Injection Needle Market Trends indicate a growing preference for disposable and safety-enhanced needles, with over 75% of procedures utilizing single-use devices. The Endoscopic Injection Needle Market Analysis shows that safety needle designs reduce accidental injuries by up to 40%, improving procedural safety.

The Endoscopic Injection Needle Market Research Report highlights that ultra-thin needles, particularly those with 25G and 26G diameters, are used in approximately 35% of precision procedures, minimizing tissue damage. Multi-function needles capable of delivering fluids and performing aspiration are adopted in nearly 20% of advanced procedures.

The Endoscopic Injection Needle Market Outlook indicates that more than 80% of healthcare facilities are transitioning to improved needle materials with higher durability, capable of withstanding pressures exceeding 10 bar. Needle lengths between 4 mm and 6 mm are used in over 60% of procedures, supporting effective submucosal injections. Increasing demand for minimally invasive procedures, exceeding 30 million annually, continues to drive innovation and adoption.

Endoscopic Injection Needle Market Dynamics

DRIVER:

"Increasing prevalence of gastrointestinal disorders and bleeding cases"

The Endoscopic Injection Needle Market Growth is driven by rising gastrointestinal disorders, with more than 1.8 million bleeding cases annually worldwide. The Endoscopic Injection Needle Market Insights indicate that approximately 70% of therapeutic endoscopies require injection-based interventions. Hospitals performing more than 2,500 procedures annually depend on injection needles for hemostasis and lesion management. Colonoscopy and upper GI procedures exceeding 30 million annually require injection therapy in approximately 65% of cases. Additionally, early intervention reduces complication rates by up to 25%, supporting demand for high-precision needles.

RESTRAINT:

"Procedural risks and high cost of advanced devices"

The Endoscopic Injection Needle Market Analysis identifies procedural risks such as perforation and improper injection occurring in approximately 3–7% of cases. The Endoscopic Injection Needle Industry Analysis indicates that advanced safety needles cost up to 20–30% higher than standard devices, limiting adoption in cost-sensitive regions. Healthcare facilities performing over 1,000 procedures annually must manage equipment costs and training requirements. Additionally, specialized training lasting 6–9 months is required for effective needle usage, limiting availability of skilled professionals.

OPPORTUNITY:

"Technological advancements in needle design and materials"

The Endoscopic Injection Needle Market Opportunities are expanding with innovations in needle materials and safety features. New needle designs reduce tissue trauma by up to 30%, improving patient outcomes. The Endoscopic Injection Needle Market Forecast indicates that more than 85% of hospitals are adopting advanced needle systems with improved durability. Multi-lumen needles are used in approximately 20% of complex procedures, enabling multiple functions in a single device. Additionally, improved coatings enhance needle lifespan by up to 50%, increasing efficiency.

CHALLENGE:

"Regulatory compliance and standardization issues"

The Endoscopic Injection Needle Market Challenges include compliance with regulatory standards across more than 120 countries, increasing complexity for manufacturers. Approval processes require clinical validation involving over 500 patients per study, delaying product launches. Needle performance must meet safety thresholds with complication rates below 5%, requiring extensive testing. Healthcare facilities performing more than 5,000 procedures annually must adhere to strict protocols, increasing operational complexity.

Download FREE Sample to learn more about this report.

Segmentation Analysis

By Type

• Diameter 19G: 19G needles account for approximately 12% of the Endoscopic Injection Needle Market Share, primarily used in procedures requiring higher flow rates. These needles are utilized in approximately 20% of hemostasis procedures, delivering larger volumes efficiently. Hospitals performing over 2,500 procedures annually prefer 19G needles for complex interventions.
• Diameter 22G: 22G needles represent approximately 36% of the Endoscopic Injection Needle Market Size, widely used in routine procedures. These needles provide balanced performance, used in approximately 50% of gastrointestinal injections. Clinics performing up to 40 procedures daily rely on 22G needles for versatility.
• Diameter 23G: 23G needles account for approximately 24% of the market, commonly used in moderate precision procedures. These needles reduce tissue trauma by up to 15%, improving outcomes. Hospitals performing over 2,000 procedures annually utilize 23G needles for balanced performance.
• Diameter 25G: 25G needles represent approximately 18% of the market, used in precision procedures requiring minimal tissue damage. These needles are used in approximately 30% of advanced procedures, reducing complication rates by up to 20%.
• Diameter 26G: 26G needles account for approximately 6% of the market, used in highly specialized procedures. These ultra-thin needles minimize tissue trauma by up to 25%, supporting delicate interventions.
• Others: Other needle types represent approximately 4% of the market, including specialized designs for niche applications. These needles are used in approximately 10% of advanced procedures.

By Application

• Hospitals: Hospitals account for approximately 64% of the Endoscopic Injection Needle Market Share, with more than 7,000 hospitals globally performing endoscopic procedures. These facilities conduct over 2,500 procedures annually, requiring advanced needle systems.
• Clinics: Clinics represent approximately 26% of the market, including outpatient centers performing over 12 million procedures annually. These facilities rely on efficient and cost-effective needle systems.
• Others: Other applications account for approximately 10% of the market, including research institutions and specialty centers performing advanced procedures.

Download FREE Sample to learn more about this report.

Regional Outlook

North America

North America holds approximately 38% of the Endoscopic Injection Needle Market Share, with over 18 million endoscopic procedures annually. The region has more than 7,000 hospitals and 16,000 outpatient centers, driving demand. Injection needles are used in approximately 85% of therapeutic procedures, with safety needles reducing injury rates by up to 40%. Hospitals perform up to 3,000 procedures annually, requiring high-performance devices.

Europe

Europe accounts for approximately 29% of the Endoscopic Injection Needle Market Share, supported by more than 6,000 healthcare facilities. The region conducts over 14 million endoscopic procedures annually, with injection needles used in approximately 75% of cases. Screening programs cover approximately 60% of target populations, increasing demand.

Asia-Pacific

Asia-Pacific represents approximately 25% of the Endoscopic Injection Needle Market Share, driven by increasing healthcare investments. The region conducts over 25 million procedures annually, with rapid adoption of advanced needle systems. More than 12,000 healthcare facilities support market growth.

Middle East & Africa

The Middle East & Africa account for approximately 8% of the Endoscopic Injection Needle Market Share, with expanding healthcare infrastructure. The region conducts over 6 million procedures annually, with increasing adoption of injection needle technologies.

List of Top Endoscopic Injection Needle Companies

• Cook Medical
• Boston Scientific
• Steris
• Carbon Medical Technologies
• GI Supply
• Endo-Therapeutics
• Ace Medical Devices
• Conmed
• MTW Endoskopie Manufaktur
• Olympus
• Upex-med
• Changzhou Jiuhong Medical
• AteTec
• Jiangsu Grit Medical

Top Companies with Highest Market Share

• Boston Scientific devices are used in over 32% of endoscopic procedures globally.
• Cook Medical supplies injection needles utilized in more than 28% of healthcare facilities worldwide.

Investment Analysis and Opportunities

The Endoscopic Injection Needle Market Opportunities are expanding with increasing investments in healthcare infrastructure. More than 12,000 new healthcare facilities are established annually, each requiring endoscopic devices. Hospitals performing over 2,500 procedures annually invest in advanced injection needles to improve outcomes.

Outpatient centers conducting more than 12 million procedures annually are adopting cost-effective needle systems. Investments in research and development include over 300 clinical studies focused on needle performance. Additionally, screening programs targeting populations exceeding 600 million individuals globally drive demand. Emerging markets with healthcare access below 55% coverage present significant opportunities for expansion.

New Product Development

The Endoscopic Injection Needle Market Trends in innovation focus on improving safety and precision. New needle designs reduce tissue trauma by up to 30%, improving patient outcomes. Safety-enhanced needles reduce accidental injuries by up to 40%.

Manufacturers are developing multi-lumen needles used in approximately 20% of advanced procedures, enabling multiple functions. Improved coatings extend needle lifespan by up to 50%, increasing durability. Additionally, new materials enhance pressure resistance beyond 10 bar, supporting complex procedures. Smart needle technologies improve injection accuracy by up to 15%, ensuring consistent performance across more than 90% of procedures.

Five Recent Developments (2023-2025)

• 2023: A safety needle design reduced injury rates by 40%.
• 2024: A multi-lumen needle improved procedural efficiency by 20%.
• 2024: A coating technology increased needle durability by 50%.
• 2025: A precision needle improved injection accuracy by 15%.
• 2023: An ultra-thin needle reduced tissue trauma by 25%.

Report Coverage of Endoscopic Injection Needle Market

The Endoscopic Injection Needle Market Report provides comprehensive analysis of product types, applications, and regional distribution. The report evaluates more than 40 manufacturers and analyzes procedure volumes exceeding 30 million annually.

The Endoscopic Injection Needle Market Research Report covers needle diameters ranging from 19G to 26G, along with applications in hospitals, clinics, and specialty centers. Facilities performing more than 2,500 procedures annually are analyzed to understand demand patterns.

The Endoscopic Injection Needle Market Insights include performance metrics such as pressure resistance exceeding 10 bar and complication rates below 5%. Regional analysis spans 4 major regions, covering patient populations exceeding 600 million under screening programs, providing detailed insights into market trends and opportunities.